Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1

por Jie Liu, Jie Liu, Jie Liu, Zhen-Ni Guo, Zhen-Ni Guo, Zhen-Ni Guo, Xiu-Li Yan, Yi Yang, Yi Yang, Yi Yang, Shuo Huang, Shuo Huang, Shuo Huang
Publicado 2021

Deciphering the mechanisms underlying brain alterations and cognitive impairment in congenital myotonic dystrophy

por Thiéry De Serres-Bérard, Marion Pierre, Mohamed Chahine, Jack Puymirat
Publicado 2021

Expanded DMPK repeats in dizygotic twins referred for diagnosis of autism versus absence of expanded DMPK repeats at screening of 330 children with autism

por Musova Z, Hancarova M, Havlovicova M, Pourova R, Hrdlicka M, Kraus J, Trkova M, Stejskal D, Sedlacek Z
Publicado 2016

Orexin/hypocretin levels in the cerebrospinal fluid and characteristics of patients with myotonic dystrophy type 1 with excessive daytime sleepiness

por Omori Y, Kanbayashi T, Imanishi A, Tsutsui K, Sagawa Y, Kikuchi YS, Takeshima M, Yoshizawa K, Uemura S, Shimizu T
Publicado 2018